Skip to main content
Top

International Journal of Hematology

Issue 3/2021

Content (23 Articles)

Optic Neuritis Images in Hematology

The eyes have it: CNS leukemia presenting as optic neuritis

Kevin A. Quann, Robert L. Redner

Computed Tomography Images in Hematology

Extramedullary hematopoiesis of the cranial dura

Keito Suto, Junichi Sugita, Daigo Hashimoto, Hiroyuki Kameda, Tomoko Mitsuhashi, Takanori Teshima

Computed Tomography Images in Hematology

Multiple lung lesions in a 13-year-old girl with classical nodular sclerosis Hodgkin Lymphoma

Shuhei Adachi, Akira Takebayashi, Kotoe Iesato, Keita Igarashi, Masaki Yamamoto, Tsukasa Hori, Yukihiko Kawasaki, Taijiro Mishina, Shintaro Sugita

Coronavirus Review Article

Diagnosis and treatment of disseminated intravascular coagulation in COVID-19 patients: a scoping review

Hirotaka Mori, Hiroshi Ohkawara, Ryuichi Togawa, Mami Rikimaru, Yoko Shibata, Takayuki Ikezoe

Anticoagulant Review Article

Ethnic differences in thromboprophylaxis for COVID-19 patients: should they be considered?

Toshiaki Iba, Jean Marie Connors, Alex C. Spyropoulos, Hideo Wada, Jerrold H. Levy

Venous Thrombosis Rapid Communication

High incidence of venous thrombosis in patients with moderate-to-severe COVID-19

Oleg Kerbikov, Pavel Orekhov, Ekaterina Borskaya, Natalia Nosenko

Bisphosphonate Original Article

Histidine decarboxylase deficiency inhibits NBP-induced extramedullary hematopoiesis by modifying bone marrow and spleen microenvironments

Hirotada Otsuka, Yasuo Endo, Hiroshi Ohtsu, Satoshi Inoue, Syunya Noguchi, Masanori Nakamura, Satoshi Soeta

Acute Myeloid Leukemia Original Article

Clinical outcomes of gemtuzumab ozogamicin for relapsed acute myeloid leukemia: single-institution experience

Naoko Hosono, Miyuki Ookura, Hiroaki Araie, Mihoko Morita, Kazuhiro Itoh, Yasufumi Matsuda, Takahiro Yamauchi

Lymphoma Original Article

Phase 1/2 study of venetoclax, a BCL-2 inhibitor, in Japanese patients with relapsed or refractory chronic lymphocytic leukemia and small lymphocytic lymphoma

Koji Izutsu, Kazuhito Yamamoto, Koji Kato, Takayuki Ishikawa, Noriko Fukuhara, Yasuhito Terui, Ilseung Choi, Kathryn Humphrey, Su Young Kim, Sumiko Okubo, Natsumi Ogawa, Yasuko Nishimura, Ahmed Hamed Salem, Dai Maruyama

Multiple Myeloma Original Article

EWSR1 overexpression is a pro-oncogenic event in multiple myeloma

Daichi Nishiyama, Yoshiaki Chinen, Reiko Isa, Yuto Fujibayashi, Saeko Kuwahara-Ota, Junko Yamaguchi, Tomoko Takimoto-Shimomura, Yayoi Matsumura-Kimoto, Taku Tsukamoto, Yuji Shimura, Tsutomu Kobayashi, Shigeo Horiike, Masafumi Taniwaki, Hiroshi Handa, Junya Kuroda

Combination of clofarabine, etoposide, and cyclophosphamide in adult relapsed/refractory acute lymphoblastic leukemia: a phase 1/2 dose-escalation study by the Japan Adult Leukemia Study Group

Takeshi Saito, Yoshihiro Hatta, Fumihiko Hayakawa, Tsutomu Takahashi, Maki Hagihara, Hiroatsu Iida, Koichiro Minauchi, Etsuko Yamazaki, Isamu Sugiura, Tohru Murayama, Toru Sakura, Naoki Mori, Kiyotoshi Imai, Yuichi Yahagi, Yoshiko Atsuta, Akiko Moriya Saito, Akihiro Hirakawa, Hitoshi Kiyoi, Itaru Matsumura, Yasushi Miyazaki

Lymphoma Original Article

Safety profile of brentuximab vedotin in Japanese patients with relapsed/refractory Hodgkin lymphoma or systemic anaplastic large cell lymphoma: a post-marketing surveillance study

Koji Izutsu, Michinori Ogura, Kensei Tobinai, Kiyohiko Hatake, Shigeru Sakamoto, Masanori Nishimura, Miyako Hoshino

Long-term safety and efficacy of imatinib in pediatric patients with chronic myeloid leukemia: single-center experience from China

Yuli Cai, Chao Liu, Ye Guo, Xiaojuan Chen, Li Zhang, Yumei Chen, Yao Zou, Wenyu Yang, Xiaofan Zhu

Multiple Myeloma Original Article

A study of carfilzomib and dexamethasone in patients with relapsed and refractory multiple myeloma in China

Juan Du, Baijun Fang, Jian Li, Jie Jin, Shunqing Wang, Dehui Zou, Zhen Cai, Hongxiang Wang, Jianda Hu, Wei Li, Chengcheng Fu, Zonghong Shao, Zhongjun Xia, Peng Liu, Ting Niu, En-Tzu Tang, Amy S. Kimball, Jian Hou, Wenming Chen

Antibiotic Original Article

Meropenem versus piperacillin/tazobactam for febrile neutropenia in pediatric patients: efficacy of piperacillin/tazobactam as a 1-h drip infusion four times a day

Ryoji Kobayashi, Hirozumi Sano, Satoru Matsushima, Daiki Hori, Masato Yanagi, Koya Kodama, Daisuke Suzuki, Kunihiko Kobayashi

Tick Original Article

Virus-infected peripheral blood plasmablasts in a patient with severe fever with thrombocytopenia syndrome

Toru Takahashi, Kaori Sano, Tadaki Suzuki, Takuro Matsumura, Kohei Sakai, Takayuki Tominaga, Yuko Sato, Harutaka Katano, Hideki Hasegawa

Dasatinib induces endothelial-to-mesenchymal transition in human vascular-endothelial cells: counteracted by cotreatment with bosutinib

Lobna Alkebsi, Xintao Wang, Hiroshi Ohkawara, Masahiko Fukatsu, Hirotaka Mori, Takayuki Ikezoe

Rituximab Case Report

Humanized anti CD-20 as an alternative in chronic management of relapsing thrombotic thrombocytopenic microangiopathy resistant to rituximab due to anti chimeric antibody

Pedram Ahmadpoor, Cedric Aglae, Florian Garo, Sylvain Cariou, Sophie Renaud, Pascal Reboul, Olivier Moranne

Myelodysplastic Syndrome Letter to the Editor

Salvage therapy with 2-chlorodeoxyadenosine for refractory and relapsed pediatric Langerhans cell histiocytosis: an updated nationwide survey in Japan

Maki Taniguchi, Kenichi Sakamoto, Yoko Shioda, Takehiko Doi, Ko Kudo, Hisanori Fujino, Kazuko Kudo, Akira Morimoto

Correction to: Impact of cGVHD on socioeconomic outcomes in survivors with pediatric hematopoietic stem cell transplant in Japan: a cross-sectional observational study

Takafumi Soejima, Masaaki Shiohara, Yasushi Ishida, Masami Inoue, Akira Hayakawa, Atsushi Sato, Kiyoko Kamibeppu, Yoshiko Atsuta, Takuya Yamashita

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine